In the high-stakes world of clinical trials, there is a pervasive misconception among executives that "more sites" and "big-name institutions" are the silver bullets for meeting enrollment deadlines. The logic seems sound: partner with a subject matter expert at a world-renowned hospital to gain instant credibility and access to vast patient pools.

Securing government funding is a major milestone for any life sciences company—preserving runway and validating your science. But why does the transition to active clinical execution so often lead to gridlock?

Curious about SEED funding but unsure where to begin? Discover the key differences between SBIR and STTR, and how CRO Consulting can guide you through every step of your funding journey!